UPMC Shadyside
Pittsburgh, Pennsylvania, 15232, United States
NCT Number: NCT03211806
The goal of this research is to develop and test a technology-supported intervention to reduce sedentary behavior before and after cancer surgery. Surgical oncology patients are at elevated risk for postoperative complications and readmissions. Sedentary behavior increases markedly after surgery and hospitalization, and reducing sedentary behavior around the time of cancer surgery could reduce risk while also empowering cancer patients to take a more active role in their recovery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15232, United States
Colorectal or peritoneal cancer patients scheduled for surgical resection (n=60) will be randomized to either the sedentary behavior intervention or monitoring only. The intervention will use a Bluetooth-enabled activity monitor to detect prolonged sedentary bouts, which will prompt a message delivered via smartphone suggesting that patients walk. The intervention will begin at least two weeks prior to scheduled surgery and will continue through the first 30 days at home following hospital discharge. Outcomes will include objective activity and sedentary behavior, patient-reported symptoms and quality of life using standardized instruments, inflammatory biomarkers, and morbidity and hospital readmission 30-days after index discharge.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Messages delivered via smartphone prompting patients to walk after prolonged sedentary behavior bouts are detected via Bluetooth-enabled activity monitor
Monitoring activity using a Bluetooth-enabled activity monitor
Time frame: 30 days post-discharge
Percentage of those enrolled who completed the program
Time frame: 30-days post-discharge
Post-intervention interviews will be conducted to assess acceptability of the program
Time frame: 30-days post-discharge
Percentages of assessments completed and prompts after which steps were detected
Time frame: Change from baseline to 30 days post-discharge
A Bluetooth enabled activity monitor worn throughout the study will estimate the total amount of time spent in sedentary behavior per day
Time frame: Change from baseline to 30 days post-discharge
A Bluetooth enabled activity monitor worn throughout the study will estimate of number of steps/day.
Time frame: Change from baseline to 30 days post-discharge
Depressive (CES-D) and physical symptom severity (adapted from the MD Anderson Symptom Inventory)
Time frame: Change from baseline to 30 days post-discharge
Quality of life (FACT)
Time frame: 2 weeks post-discharge
Plasma levels of IL-6 and CRP
Time frame: 30 days post-discharge
Grade 3-4 surgical complications within 30 days after index hospital discharge will be extracted from medical records
Time frame: Change from baseline to 30 days post-discharge
A Bluetooth enabled activity monitor will be used to estimate mean daily sedentary bout
Time frame: Change from baseline to 30 days post-discharge
A Bluetooth enabled activity monitor will be used to estimate maximum daily sedentary bout
Time frame: 30 days post-discharge
Readmissions within 30 days after index hospital discharge will be extracted from medical records
University of Pittsburgh
Other
Technology to Reduce Sedentary Behavior Before and After Cancer Surgery
Acronym: DASH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03575117
Behavior, Colonic Diseases
Merced, California, United States
View Trial DetailsNCT06184867
Adnexal Diseases, Breast Cancer
New Brunswick, New Jersey, United States
View Trial DetailsNCT04088786
Adenocarcinoma, Adenocarcinoma, Mucinous
Lexington, Kentucky, United States
View Trial DetailsNCT02442583
Behavior, Colonic Diseases
Durham, North Carolina, United States
View Trial Details